On Tuesday, Elevance Health Inc (NYSE: ELV) opened lower -4.94% from the last session, before settling in for the closing price of $509.02. Price fluctuations for ELV have ranged from $435.99 to $567.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 13.24% over the last five years. Company’s average yearly earnings per share was noted 12.40% at the time writing. With a float of $230.93 million, this company’s outstanding shares have now reached $233.07 million.
The firm has a total of 104900 workers. Let’s measure their productivity. In terms of profitability, gross margin is 89.44%, operating margin of 22.46%, and the pretax margin is 5.0%.
Elevance Health Inc (ELV) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of Elevance Health Inc is 0.41%, while institutional ownership is 92.31%. The most recent insider transaction that took place on Aug 05 ’24, was worth 400,235. In this transaction Director of this company sold 753 shares at a rate of $531.52, taking the stock ownership to the 8,744 shares. Before that another transaction happened on Aug 05 ’24, when Company’s Director proposed sale 753 for $531.52, making the entire transaction worth $400,235.
Elevance Health Inc (ELV) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 12.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.09% during the next five years compared to 12.18% growth over the previous five years of trading.
Elevance Health Inc (NYSE: ELV) Trading Performance Indicators
Check out the current performance indicators for Elevance Health Inc (ELV). In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.65. Likewise, its price to free cash flow for the trailing twelve months is 136.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 28.52, a number that is poised to hit 9.66 in the next quarter and is forecasted to reach 41.65 in one year’s time.
Technical Analysis of Elevance Health Inc (ELV)
Analysing the last 5-days average volume posted by the [Elevance Health Inc, ELV], we can find that recorded value of 1.25 million was better than the volume posted last year of 1.03 million. As of the previous 9 days, the stock’s Stochastic %D was 46.56%. Additionally, its Average True Range was 11.06.
During the past 100 days, Elevance Health Inc’s (ELV) raw stochastic average was set at 1.37%, which indicates a significant decrease from 2.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.78% in the past 14 days, which was higher than the 24.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $530.19, while its 200-day Moving Average is $518.84. Now, the first resistance to watch is $490.34. This is followed by the second major resistance level at $496.82. The third major resistance level sits at $500.63. If the price goes on to break the first support level at $480.05, it is likely to go to the next support level at $476.24. Now, if the price goes above the second support level, the third support stands at $469.76.
Elevance Health Inc (NYSE: ELV) Key Stats
There are currently 232,418K shares outstanding in the company with a market cap of 112.20 billion. Presently, the company’s annual sales total 171,340 M according to its annual income of 5,987 M. Last quarter, the company’s sales amounted to 43,886 M and its income totaled 2,300 M.
